Longeveron (LGVN) Cash & Equivalents (2021 - 2026)
Longeveron (LGVN) recorded Cash & Equivalents of $10.1 million in Q2 2026, down 2.3% from $10.33 million a year earlier and down 36.1% from the prior quarter.
Powered by 
Analysis
Longeveron (LGVN) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Longeveron reported Cash & Equivalents of $4.66 million, down 75.8% from FY2024.
- Annual Cash & Equivalents has a four-year compound annual growth rate of -34.7% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $19.23 million in FY2024 (+288.6%), $4.95 million in FY2023 (-52.9%), $10.5 million in FY2022 (-59.1%) and $25.66 million in FY2021.
- Quarterly Cash & Equivalents has ranged from $1.9 million in Q1 2023 to $25.66 million in Q4 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with growth averaging 111.9%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 638.5% in Q1 2025, against a decline of 75.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $15.8 million (Q1 2026), $4.66 million (Q4 2025) and $9.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Longeveron | 7.81 Mn | -32.00 Mn | 182,000.00 | 10.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.10 Mn |
| Mar 31, 2026 | 15.80 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 9.24 Mn |
| Jun 30, 2025 | 10.33 Mn |
| Mar 31, 2025 | 14.33 Mn |
| Dec 31, 2024 | 19.23 Mn |
| Sep 30, 2024 | 22.80 Mn |
| Jun 30, 2024 | 12.40 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 2.75 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 10.50 Mn |
| Dec 31, 2021 | 25.66 Mn |
API Access
Longeveron Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();